(Raleigh, N.C.) Treasurer Dale R. Folwell, CPA, is calling today for the State Health Plan (Plan) Board of Trustees to end coverage of popular GLP-1 drugs like Wegovy and Saxenda for the purpose of weight loss until the drugs’ manufacturer, Danish multinational Novo Nordisk, prices the drugs fairly.